NCT05001776View on ClinicalTrials.gov

Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Superficial Vein ThrombosisEndovenous Laser Ablation
Interventions
PROCEDURE

Endovenous laser ablation

Laser ablation of the great saphenous vein close to sapheno-femoral junction

DRUG

Fondaparinux Sodium

Fondaparinux sodium for 7 days or 45 days

Trial Locations (1)

10100

National Medical Research Center for Therapy and Preventive Medicinel, Moscow

All Listed Sponsors
lead

National Medical Research Center for Therapy and Preventive Medicine

OTHER_GOV

NCT05001776 - Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein | Biotech Hunter | Biotech Hunter